Clinical characteristics and risk factors of drug‐induced lung injury by ALK tyrosine kinase inhibitors: A single center retrospective analysis

BACKGROUND: If anaplastic lymphoma kinase (ALK) gene rearrangement in lung cancer is identified, ALK‐tyrosine kinase inhibitors (ALK‐TKIs) can be an effective treatment. However, the details of drug‐induced lung injury (DILI) caused by ALK‐TKI, which can be a serious side effect of ALK‐TKIs, remains...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Thorac Cancer
Egile Nagusiak: Koshikawa, Ken, Terada, Jiro, Abe, Mitsuhiro, Iwasawa, Shunichiro, Sakayori, Masashi, Yoshioka, Keiichiro, Hirasawa, Yasutaka, Kasai, Hajime, Kawasaki, Yohei, Tsushima, Kenji, Tatsumi, Koichiro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons Australia, Ltd 2020
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7262910/
https://ncbi.nlm.nih.gov/pubmed/32237210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13416
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak